The health care start up Acellus has debuted its first product this year: app-based monitoring for cancer patients.
WILMINGTON – Prelude Therapeutics, the burgeoning cancer treatment research company, recently named its first president while it furthers research on two lead drugs and preps two additional ones for studies. […]
WILMINGTON – Cancer treatment research company Prelude Therapeutics has signed a major lease for its future headquarters at the Chestnut Run Innovation and Science Park, the first new tenant at […]
WILMINGTON – Cancer research company Prelude Therapeutics recently secured $5.5 million in state taxpayer-backed grants to move to new, larger labs and more than double its workforce in the state. […]
WILMINGTON – A few days after announcing that it would offer 1.75 million new shares on the market, startup cancer research company Prelude Therapeutics increased its offering to more than […]
© 2023 Delaware Business Times